Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines
Author:
Steven Black,Juhani Eskola,Claire-Anne Siegrist,Neal Halsey,Noni MacDonald,Barbara Law,Elizabeth Miller,Nick Andrews,Julia Stowe,Daniel Salmon,Kirsten Vannice,Hector S Izurieta,Aysha Akhtar,Mike Gold,Gabriel Oselka,Patrick Zuber,Dina Pfeifer et al.
Date:
19 December 2009–1 January 2010
Copyright © 2009 Elsevier Ltd. All rights reserved.